CD55 and neoplasm: Moreover, a great deal of data showed that mCRP expression, contains CD46, CD55, and CD59, are linked to worse clinical outcomes, and in some cases highly specific for tumor cells, many approaches to block mCRP expression on tumor cells have been studied (17, 22, 84).